Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Michael J. Farrell

At a glance: Michael J. Farrell is CEO, Chair at ResMed (RMD). Their latest SEC Form 4, filed Nov 12, 2026, reported a sale of $1.2M. On file: 0 purchase lines ($0) and 14 sale lines ($18.0M).

Disclosed holdings: about $114M of RMD stock: 479,803 shares reported on their latest Form 4 (filed Nov 12, 2026), valued at the Nov 19, 2026 close of $237.09. This counts only RMD shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.

CEO at Resmed Inc (RMD); CEO, Chair at Resmed Inc (RMD)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $18.0M

Michael J. Farrell's InsiderPrint

14 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.

InsiderPrint of Michael J. Farrell: 14 trades, 2025 to 20262025: 0 buys, 3 sales2026: 0 buys, 11 sales

Reading this print: Almost only sells, trading about 13 times a year, typically $1.2M a trade; most sales are on a pre-planned 10b5-1 schedule.

  • Bump outward: a purchase (0)
  • Dent inward: a sale (14)
  • One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.

Insiders with a similar print

  1. Aaron JagdfeldCEO · GNRC · 100% match
  2. David M. RothensteinEvp & Chief Strategy Officer · CIEN · 100% match
  3. Salvatore A. MiosiCOO, President · MTG · 100% match
  4. Joseph M. ErlingerPresident · MCD · 100% match
  5. Mark KiddEvp, Gm Data Centers & Alm · IRM · 99% match

Matched on seven traits of each insider's trading pattern (buy share, pace, typical size, planned sales, seasonality, buying after drops, number of companies). Pattern matching on public filings; history, not a prediction.

Reported trades

Filed Stock Type Shares Price Value Since
Nov 12SEC RMDResmed Inc Sell Plan 4,993479,803 held (−1%) $235.35 $1.2M +0.7%
Oct 8SEC RMDResmed Inc Sell Plan 4,991479,803 held (−1%) $226.33 $1.1M +4.7%
Sep 10SEC RMDResmed Inc Sell Plan 4,991466,256 held (−1%) $222.44 $1.1M +6.6%
Aug 11SEC RMDResmed Inc Sell Plan 4,991466,256 held (−1%) $205.69 $1.0M +15.3%
Jul 9SEC RMDResmed Inc Sell Plan 4,991466,223 held (−1%) $218.55 $1.1M +8.5%
Jun 9SEC RMDResmed Inc Sell Plan 4,991466,256 held (−1%) $193.96 $968K +22.2%
May 11SEC RMDResmed Inc Sell Plan 4,991466,223 held (−1%) $207.82 $1.0M +14.1%
Apr 9SEC RMDResmed Inc Sell Plan 4,991466,223 held (−1%) $225.50 $1.1M +5.1%
Mar 11SEC RMDResmed Inc Sell Plan 4,991466,223 held (−1%) $251.03 $1.3M -5.6%
Feb 10SEC RMDResmed Inc Sell Plan 4,991466,223 held (−1%) $273.78 $1.4M -13.4%
Jan 8SEC RMDResmed Inc Sell Plan 4,991466,223 held (−1%) $248.46 $1.2M -4.6%
Dec 9SEC RMDResmed Inc Sell Plan 4,991466,223 held (−1%) $251.41 $1.3M -5.7%
Nov 10SEC RMDResmed Inc Sell Plan 8,011467,866 held (−2%) $249.75 $2.0M -5.1%
Oct 9SEC RMDResmed Inc Sell Plan 8,009467,792 held (−2%) $282.85 $2.3M -16.2%
  • Sell

    CEO, Chair Michael J. Farrell sold $1.2M of RMD at $235.35 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, Chair Michael J. Farrell sold $1.1M of RMD at $226.33 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, Chair Michael J. Farrell sold $1.1M of RMD at $222.44 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, Chair Michael J. Farrell sold $1.0M of RMD at $205.69 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, Chair Michael J. Farrell sold $1.1M of RMD at $218.55 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CEO, Chair Michael J. Farrell sold $968K of RMD at $193.96 — pre-scheduled 10b5-1 plan sale.

Follow Michael J. Farrell

Get one email when Michael J. Farrell files a new purchase or sale. Free.

At most one email a day about Michael J. Farrell, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.